{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:42:24Z","timestamp":1790728944893,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.dld.2019.03.023","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T08:02:34Z","timestamp":1555660954000},"page":"761-768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Recent updates on alcoholic hepatitis"],"prefix":"10.1016","volume":"51","author":[{"given":"Lindsey C.","family":"Shipley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Kodali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-7285","authenticated-orcid":false,"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2019.03.023_bib0005","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/acer.13108","article-title":"Diagnosis and treatment of alcoholic hepatitis: a systematic review","volume":"40","author":"Singal","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.dld.2019.03.023_bib0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhep.2018.05.001","article-title":"Grand rounds: alcoholic hepatitis","volume":"69","author":"Singal","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0015","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.03.023_bib0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0025","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.03.023_bib0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-230X-13-55","article-title":"White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers","volume":"13","author":"Hardy","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2019.03.023_bib0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0036-1571297","article-title":"Therapeutic strategies for the treatment of alcoholic hepatitis","volume":"36","author":"Singal","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2019.03.023_bib0050","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.gtc.2011.06.008","article-title":"Alcoholic hepatitis: prognostic models and treatment","volume":"40","author":"Singal","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.dld.2019.03.023_bib0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0065","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/liv.12939","article-title":"Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials","volume":"36","author":"Hmoud","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.03.023_bib0070","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0075","first-page":"282","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"373","author":"Thursz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.03.023_bib0080","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.03.023_bib0085","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.25544","article-title":"Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database","volume":"55","author":"Singal","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0090","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.12427","article-title":"Determinants of long-term outcome in severe alcoholic hepatitis","volume":"38","author":"Potts","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.03.023_bib0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2013.06.013","article-title":"Alcoholic hepatitis: current challenges and future directions","volume":"12","author":"Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4254\/wjh.v3.i5.118","article-title":"Symptoms and signs of acute alcoholic hepatitis","volume":"3","author":"Basra","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0300-5089(21)00818-X","article-title":"Alcoholic hepatitis","volume":"10","author":"Mendenhall","year":"1981","journal-title":"Clin Gastroenterol"},{"key":"10.1016\/j.dld.2019.03.023_bib0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhep.2018.05.001","article-title":"Grand rounds: alcoholic hepatitis","volume":"69","author":"Singal","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0115","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2008.10.028","article-title":"Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats","volume":"50","author":"Keshavarzian","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0120","doi-asserted-by":"crossref","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2019.03.023_bib0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0168-8278(01)00276-8","article-title":"Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis","volume":"36","author":"Taieb","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0130","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O\u2019Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0140","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1365-2036.2007.03258.x","article-title":"Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis","volume":"25","author":"Rincon","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.03.023_bib0145","doi-asserted-by":"crossref","first-page":"414","DOI":"10.14218\/JCTH.2017.00044","article-title":"Severe alcoholic hepatitis: atypical presentation with markedly elevated alkaline phosphatase","volume":"5","author":"Axley","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0150","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/S0168-8278(14)60491-8","article-title":"Baseline liver biopsy can predict response to steroids in patients with severe alcoholic hepatitis","volume":"60","author":"Shasthry","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0155","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2013-306098","article-title":"CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis","volume":"63","author":"Affo","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.03.023_bib0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-015-0623-9","article-title":"Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis","volume":"13","author":"Momen-Heravi","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.dld.2019.03.023_bib0165","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ajg.2015.181","article-title":"Corrigendum: PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease","volume":"110","author":"Salameh","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.03.023_bib0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/hep4.1123","article-title":"Interaction between the patatin-like phospholipase domain-containing protein 3 genotype and coffee drinking and the risk for acute alcoholic hepatitis","volume":"2","author":"Liangpunsakul","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2019.03.023_bib0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0180","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cgh.2013.08.048","article-title":"The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis","volume":"12","author":"Hanouneh","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0185","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep4.1176","article-title":"Baseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome","volume":"2","author":"Maras","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2019.03.023_bib0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20140101","article-title":"The Bioenergetic Health Index: a new concept in mitochondrial translational research","volume":"127","author":"Chacko","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.dld.2019.03.023_bib0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3727\/105221618X15325235888914","article-title":"Review article: cellular abnormalities and emerging biomarkers in alcohol associated liver disease","volume":"19","author":"Singal","year":"2018","journal-title":"Gene Expr"},{"key":"10.1016\/j.dld.2019.03.023_bib0200","first-page":"986A","article-title":"Patients with severe alcoholic hepatitis and hepatorenal syndrome require a new therapeutic strategy","volume":"56","author":"Louvet","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0891-5849(01)00742-0","article-title":"Role of malondialdehyde-acetaldehyde adducts in liver injury","volume":"32","author":"Tuma","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.dld.2019.03.023_bib0210","first-page":"305","article-title":"Malondialdehyde as a prognostic factor in alcoholic hepatitis","volume":"52","author":"Perez-Hernandez","year":"2017","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.dld.2019.03.023_bib0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4254\/wjh.v2.i8.295","article-title":"Mallory-Denk body pathogenesis revisited","volume":"2","author":"French","year":"2010","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0220","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2013.12.026","article-title":"Biomarkers of liver cell death","volume":"60","author":"Eguchi","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3727\/105221617X15016197658871","article-title":"Cell death and prognosis of mortality in alcoholic hepatitis patients using plasma Keratin-18","volume":"17","author":"Woolbright","year":"2017","journal-title":"Gene Expr"},{"key":"10.1016\/j.dld.2019.03.023_bib0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cytogfr.2008.08.001","article-title":"Osteopontin: role in immune regulation and stress responses","volume":"19","author":"Wang","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.dld.2019.03.023_bib0235","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.26521","article-title":"Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis","volume":"58","author":"Morales-Ibanez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113860","article-title":"Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways","volume":"9","author":"Rachakonda","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.03.023_bib0245","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1111\/acer.12558","article-title":"Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines","volume":"38","author":"Rachakonda","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.dld.2019.03.023_bib0250","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/hep.29623","article-title":"The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0255","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.29338","article-title":"Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival","volume":"66","author":"Altamirano","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/alcalc\/agu028","article-title":"Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis","volume":"49","author":"Yamini","year":"2014","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.dld.2019.03.023_bib0265","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/0148607195019004258","article-title":"Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275","volume":"19","author":"Mendenhall","year":"1995","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.dld.2019.03.023_bib0270","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0275","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2017.02.030","article-title":"Infection in severe alcoholic hepatitis: yet another piece in the puzzle","volume":"152","author":"Singal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0280","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1196\/annals.1321.009","article-title":"Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies","volume":"1024","author":"Franchimont","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.dld.2019.03.023_bib0285","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0290","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007339.pub2","article-title":"Pentoxifylline for alcoholic hepatitis","author":"Whitfield","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2019.03.023_bib0295","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","author":"easloffice@easloffice.eu EAftSotLEa, Liver EAftSot","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0300","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0305","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0310","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002800.pub3","article-title":"Propylthiouracil for alcoholic liver disease","author":"Fede","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2019.03.023_bib0315","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"Thompson","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2019.03.023_bib0320","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1478-3231.2011.02604.x","article-title":"Antioxidants as therapeutic agents for liver disease","volume":"31","author":"Singal","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.03.023_bib0325","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.03.023_bib0330","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.3748\/wjg.v21.i16.4975","article-title":"Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis","volume":"21","author":"Higuera-de la Tijera","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.03.023_bib0335","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0340","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4254\/wjh.v3.i8.205","article-title":"Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: current status","volume":"3","author":"Singal","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0345","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A day-4 lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.03.023_bib0350","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0355","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/hep.23666","article-title":"Theophylline improves steroid sensitivity in acute alcoholic hepatitis","volume":"52","author":"Kendrick","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0360","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4254\/wjh.v3.i8.215","article-title":"Liver transplantation in acute alcoholic hepatitis: current status and future development","volume":"3","author":"Singal","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0365","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/lt.500030613","article-title":"Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases","volume":"3","author":"Lucey","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.dld.2019.03.023_bib0370","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.3748\/wjg.v19.i36.5953","article-title":"Liver transplantation in alcoholic liver disease current status and controversies","volume":"19","author":"Singal","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.03.023_bib0375","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2018.11.007","article-title":"Liver transplantation for alcoholic hepatitis","volume":"70","author":"Im","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0380","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/alcalc\/agl033","article-title":"Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria","volume":"41","author":"McCallum","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.dld.2019.03.023_bib0385","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/lt.21298","article-title":"The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation","volume":"13","author":"Wells","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2019.03.023_bib0390","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early liver transplantation for severe alcoholic hepatitis in the United States\u2014a single-center experience","volume":"16","author":"Im","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2019.03.023_bib0395","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/lt.24208","article-title":"Liver transplantation for alcoholic hepatitis: a survey of liver transplant centers","volume":"21","author":"Hasanin","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2019.03.023_bib0400","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190823","article-title":"Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis","volume":"13","author":"Marot","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.03.023_bib0410","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/ajt.13176","article-title":"Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation","volume":"15","author":"Stroh","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2019.03.023_bib0415","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/liv.12939","article-title":"Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials","volume":"36","author":"Hmoud","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.03.023_bib0420","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis","volume":"60","author":"Gustot","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0425","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2018.10.026","article-title":"Current trials and novel therapeutic targets for alcoholic hepatitis","volume":"70","author":"Singal","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0430","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.26494","article-title":"Microbiota-liver axis in hepatic disease","volume":"59","author":"Chassaing","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0435","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0440","first-page":"378","article-title":"Bovine colostrums: a review of clinical uses","volume":"8","author":"Kelly","year":"2003","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.dld.2019.03.023_bib0445","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cld.2012.08.009","article-title":"Nutrition in alcoholic liver disease","volume":"16","author":"Singal","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2019.03.023_bib0450","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11938-017-0132-4","article-title":"Role of zinc in the development\/progression of alcoholic liver disease","volume":"15","author":"McClain","year":"2017","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.dld.2019.03.023_bib0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076522","article-title":"Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors","volume":"8","author":"Zhong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.03.023_bib0460","doi-asserted-by":"crossref","first-page":"G757","DOI":"10.1152\/ajpgi.00442.2014","article-title":"Zinc deficiency mediates alcohol-induced apoptotic cell death in the liver of rats through activating ER and mitochondrial cell death pathways","volume":"308","author":"Sun","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2019.03.023_bib0465","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0470","first-page":"5","article-title":"Recent advances in the development of farnesoid X receptor agonists","volume":"3","author":"Ali","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.dld.2019.03.023_bib0475","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/hep.26939","article-title":"Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats","volume":"59","author":"Verbeke","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0480","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2013.11.057","article-title":"Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease","volume":"443","author":"Wu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dld.2019.03.023_bib0485","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.dld.2019.03.023_bib0490","doi-asserted-by":"crossref","first-page":"1444A","DOI":"10.1002\/hep.30353","article-title":"IL-1 receptor antagonist in combination with pentoxifylline and zinc for severe alcoholic hepatitis: a multicenter randomized double blind placebo-controlled clinical trial","volume":"68","author":"Szabo","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.03.023_bib0495","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dld.2019.03.023_bib0500","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2015.11.020","article-title":"Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles","volume":"64","author":"Verma","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0505","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cgh.2018.06.012","article-title":"Emricasan improves liver function in patients with cirrhosis and high model for end-stage liver disease scores compared with placebo","volume":"17","author":"Frenette","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0510","article-title":"Selonsertib in combination with prednisolone for the treatment of severe alcoholic hepatitis: a phase 2 randonized controlled trial","author":"Mathurin","year":"2018","journal-title":"AASLD 2018"},{"key":"10.1016\/j.dld.2019.03.023_bib0515","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jhep.2015.04.003","article-title":"Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis","volume":"63","author":"Lanthier","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.03.023_bib0520","doi-asserted-by":"crossref","first-page":"G1019","DOI":"10.1152\/ajpgi.00239.2006","article-title":"IL-22-mediated liver cell regeneration is abrogated by SOCS-1\/3 overexpression in vitro","volume":"292","author":"Brand","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2019.03.023_bib0525","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","volume":"64","author":"Dubuquoy","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.03.023_bib0530","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0535","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.03.023_bib0540","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819305298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819305298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:10:06Z","timestamp":1761624606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865819305298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1590865819305298"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2019.03.023","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent updates on alcoholic hepatitis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2019.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}